| AECG | American–European Consensus Group | |
| Anti-SSA | anti-Sjögren’s syndrome-related antigen A autobodies | |
| BAFF | B-cell activating factor | |
| BOP | bleeding on probing index | |
| CAL | Gingival clinical attachment loss | |
| CASP | Caspase | |
| DMFT | Decayed, missing, and filled teeth | |
| EULAR | Sjögren’s syndrome patient reported index | |
| FFA | Free fatty acids | |
| GCF | Gingival crevicular fluid | |
| GI | Gingival index | |
| HLA | Human leukocite antigen | |
| IFN | Interferon | |
| IL | Interleukin | |
| MMP | Matrix-metalloproteinases | |
| NSPT | Non-surgical periodontal therapy | |
| PCNA | Proliferative activity of cell nuclear antigen | |
| PICO | Population Intervention Comparison Outcome | |
| PLQ | Dental plaque index | |
| PPD | Periodontal pocket depth | |
| PRISMA | Preferred Reporting Items for Systematic Review and Meta-Analyses | |
| pSS | Primary Sjögren’s syndrome | |
| RA | Rheumatoid arthritis | |
| SS | Sjögren’s syndrome | |
| sSS | Secondary Sjögren’s syndrome | |
| TGF | Tumor growth factor | |
| TNF | Tumor necrosis factor | |